Therapeutic efficacy of pharmacologic ascorbate in combination with targeted and immunotherapy in melanoma

被引：0
|
作者：
Niessner, H. [1 ]
Amaral, T. [1 ]
Burkard, M. [2 ]
Leischner, C. [2 ]
Renner, O. [2 ]
Ploger, S. [1 ]
Meraz-Torres, F. [1 ]
Bocker, M. [1 ]
Hirn, C. [1 ]
Lauer, U. [3 ]
Busch, C. [4 ]
Venturelli, S. [2 ]
Flatz, L. [1 ]
Sinnberg, T. [1 ]
机构：
[1] Univ Tubingen, Dermato Onkol, Tubingen, Germany
[2] Univ Hohenheim, Inst Nutrit Sci, Dept Nutrit Biochem, Hohenheim, Germany
[3] Univ Tubingen, Dept Internal Med 8, Tubingen, Germany
[4] Dermatol Zum Delfin, Winterthur, Switzerland
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2022年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
FV34
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [31] Rational combination of cancer immunotherapy in melanoma
    Mandala, Mario
    Rutkowski, Piotr
    VIRCHOWS ARCHIV, 2019, 474 (04) : 433 - 447
  • [32] Combination immunotherapy in management of advanced melanoma
    Kapoor, Akhil
    Rungta, Ankita
    Kumar, Harvindra Singh
    Kumar, Rajesh
    CLINICAL CANCER INVESTIGATION JOURNAL, 2014, 3 (04): : 361 - 362
  • [33] Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination therapies
    Kwong, Andrew
    Sanlorenzo, Martina
    Rappersberger, Klemens
    Vujic, Igor
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2019, 169 (13-14) : 314 - 322
  • [34] Long-term therapeutic success of sequential immunotherapy and targeted therapy in metastatic malignant melanoma
    Rudolph, V.
    Leven, A. S.
    Peller, V.
    Mueller, C.
    Scheib, C.
    Zillikens, H.
    Roesch, A.
    Ugurel, S.
    Schadendorf, D.
    Zimmer, L.
    Livingstone, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 47 - 48
  • [35] Combination of Pharmacologic Concentrations of Ascorbate with Redox Cycling Compounds as a new Anticancer Treatment
    Verrax, Julien
    Beck, Raphael
    Dejeans, Nicolas
    Glorieux, Christophe
    Taper, Henryk
    Calderon, Pedro Buc
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 : S156 - S157
  • [36] Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy
    Peng, Xueqiang
    Fang, Jianjun
    Lou, Chuyuan
    Yang, Liang
    Shan, Shaobo
    Wang, Zixian
    Chen, Yutong
    Li, Hangyu
    Li, Xuexin
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (08) : 3432 - 3456
  • [37] Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy
    Zaher, Amira
    Stephens, Laura M.
    Miller, Ann M.
    Hartwig, Stacey M.
    Stolwijk, Jeffrey M.
    Petronek, Michael S.
    Zacharias, Zeb R.
    Wadas, Thaddeus J.
    Monga, Varun
    Cullen, Joseph J.
    Furqan, Muhammad
    Houtman, Jon C. D.
    Varga, Steven M.
    Spitz, Douglas R.
    Allen, Bryan G.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [38] The Promise of Molecularly Targeted and Immunotherapy for Advanced Melanoma
    Margolin, Kim
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (09)
  • [39] The role of targeted therapy for melanoma in the immunotherapy era
    Sullivan, Ryan J.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2018, 37 (02) : 112 - 119
  • [40] Is There an Optimal Intersection for Targeted and Immunotherapy Treatments for Melanoma?
    Luke, Jason J.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (02) : 34 - 38
12345